Mealey's ( May 5, 2025, 12:55 PM EDT) -- NEW ORLEANS — The Louisiana federal judge overseeing the Taxotere hair loss multidistrict litigation granted summary judgment to two generic drug manufacturers after finding on remand from the Fifth Circuit U.S. Court of Appeals that one abstract presented at a December 2013 conference did not constitute newly acquired risk information that could have been added to the label of a chemotherapy drug that allegedly caused permanent chemotherapy-induced alopecia (PCIA) in cancer patients....